ACE Research

What ACE Research does

ACE Research (legal name: Africa Clinical Research Management Limited) is a Sub-Saharan Africa-focused Contract Research Organization founded in 2014 and headquartered in Kisumu, Kenya, with additional offices in Nairobi and Hinckley, Ohio. The company delivers full-service Phase I-IV clinical trial operations for pharmaceutical, biotechnology, and medical device sponsors, plus government health agencies, across 45+ African countries. Its service portfolio spans patient recruitment and retention, clinical monitoring, regulatory affairs, project management, pharmacovigilance, Site Management Organization (SMO), quality management (RBQM), clinical data management, biostatistics, medical writing, translation, IMP logistics, and outbreak response. ACE leverages a network of 800-1000+ high-enrolling hospitals, 60+ research-ready sites, and a 400+ community-hospital SMO platform, supported by Importer of Record (IOR) capabilities in 40+ countries and compliance with ICH-GCP, 21 CFR Part 11, CDISC, HIPAA, and GDPR standards.

The technology stack is built on standard clinical trial management infrastructure - Electronic Data Capture (EDC) systems, risk-based monitoring platforms, Clinical Data Management (CDM) systems meeting CDISC/CDASH standards, and regulatory compliance software - rather than proprietary AI-native tooling. Reported operational KPIs include 95% ethics committee approval within 60 days, 90% site activation within 45 days, 93% subject retention, 100% SAE reporting compliance, and 89% database lock within 60 days of last patient last visit. The company has a demonstrated outbreak response track record across Ebola (DRC, 2018) and COVID-19 vaccine trials.

ACE Research generates revenue through professional services contracts (project/contract-based pricing with multi-year engagements) sold via direct enterprise field sales to pharma and biotech sponsors. The go-to-market motion is anchored on localized teams (PMs, CRAs, regulatory specialists with 5+ years of experience) operating in the same time zone as trial sites, enabling cost-competitive execution against global CROs. Pricing is quote-based with no public rate cards, and the company emphasizes cost control, timeline reduction, and FDA/ICH-grade data quality as core value propositions. Leadership is led by CEO Victorine Owira, with Dr. Amos Ndhere MD, MS serving as a senior medical author and advisor.

Name

ACE Research

Legal name

Africa Clinical Research Management Limited

Website

https://aceresearchafrica.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

51–100 employees

Short description

ACE Research is a Sub-Saharan Africa-focused Contract Research Organization founded in 2014, delivering full-service Phase I-IV clinical trial operations to pharmaceutical, biotech, and medical device sponsors across 45+ countries via a 1000+ hospital network.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) / Clinical Research Services

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Other Scientific and Technical Consulting Services (541690)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Clinical Trial Site Operations & Study Coordination (HLAGACAE), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI), Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts) (HLAGACAC), Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH)

Keywords

• Clinical research services
• Contract research organization
• Clinical trial management
• Pharmacovigilance services
• Regulatory affairs consulting

Headquarters

HQ city

Kisumu

HQ country

Kenya

HQ region

Africa

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Full-Service CRO Services: ACE Research generates revenue through comprehensive contract research organization services including clinical monitoring, regulatory affairs, patient recruitment, data management, safety management, project management, and site management for Phase I-IV clinical trials. Services are billed as professional services typically on a project/contract basis.
2. Late-Phase Clinical Studies: Post-marketing studies, observational epidemiologic studies, expanded access programs, post-authorization safety studies, and pharmacovigilance services for approved products.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

ACE Research is a full-service Contract Research Organization (CRO) that plans and executes Phase I-IV clinical trials for pharmaceutical, biotechnology, medical device, and government health agency sponsors across Sub-Saharan Africa. The company delivers end-to-end clinical trial services including patient recruitment, clinical monitoring, regulatory affairs, project management, pharmacovigilance, site management, quality management, clinical data management, biostatistics, and medical writing, supported by a network of 800-1000+ high-enrolling hospitals across 45+ African countries and operates as Importer of Record (IOR) in 40+ countries.

Product overview

ACE Research is a Contract Research Organization (CRO) providing full-service clinical research solutions across Sub-Saharan Africa. The company operates as a unified platform offering integrated Phase I-IV clinical trial services for vaccines, drugs, and medical devices, encompassing patient recruitment, clinical monitoring, regulatory affairs, data management, pharmacovigilance, and site management through its network of localized teams and 1000+ hospital sites across 45+ countries. The core product portfolio includes Patient Recruitment and Retention Services, Clinical Monitoring, Regulatory Affairs, Project Management, Safety Management/Pharmacovigilance, Site Management Organization (SMO), Quality Management, Data Management (CDM), Biostatistics, Medical Writing, Translation Services, and specialized services including Outbreak Response, Capacity Building, and Rescue Studies/Late-Phase Services.

Differentiator

Problem solved

Functional benefit

Products and services

• Patient Recruitment and Retention Services Patient recruitment services providing access to 40+ high-enrolling research sites with known patient databases to achieve enrollment milestones efficiently across Sub-Saharan Africa. Intended for pharmaceutical, biotech, and device sponsors running Phase I-IV clinical trials.
• Clinical Monitoring Services Flagship clinical monitoring services for clinical trials in Africa, ensuring safety, data integrity, and compliance with ICH-GCP guidelines through risk-based monitoring approaches adapted for African clinical sites. Intended for pharmaceutical, biotech, and device sponsors.
• Regulatory Affairs Services Regulatory services providing navigation of clinical trial regulatory applications across African countries with expertise in ethics committee and regulatory authority submissions for clinical trial sponsors.
• Project Management Services Expert clinical trial project management services using PMI methodology with standardized processes and metrics, with project managers strategically located in Africa for time-zone co-location with trial sites.
• Safety Management / Pharmacovigilance Services Drug safety and pharmacovigilance services ensuring trial participant safety and regulatory compliance with 24/7 emergency readiness and AE/SAE/AESI reporting.
• Site Management Organization (SMO) Site management services providing access to over 400 community-based hospitals in Africa through centralized SMO operations with standardized quality oversight and SOPs for clinical trial sponsors.
• Quality Management Services (RBQM) Risk-Based Quality Management (RBQM) built on ICH E6(R2) GCP guidelines including risk evaluation, control, communication, review, and reporting components for clinical trial sponsors.
• Clinical Data Management Services Comprehensive Clinical Data Management (CDM) services compliant with CDISC, CDASH, 21 CFR Part 11, ICH E2A, GDP, and HIPAA standards including eCRF design, SDTM/ADaM datasets, and statistical analysis for clinical trials.
• Biostatistics Services Biostatistics services including Statistical Analysis Plan development, study design and randomization, programming of Tables, Listings, and Figures (TLFs), SDTM datasets, and clinical study reports.
• Medical Writing Services Medical writing services for clinical documents including protocols, informed consent forms, clinical study reports (CSRs), and investigator brochures for clinical trial sponsors.
• Translation Services Translation services for clinical trial documents ensuring linguistic accuracy, cultural sensitivity, and plain language for diverse populations across Africa.
• Feasibility Assessment Services Site feasibility assessment services to evaluate clinical trial site capabilities, infrastructure, and suitability for study execution across Sub-Saharan Africa.
• Community Engagement Services Community engagement services that build trust with ministries of health, communities, and stakeholders to enhance recruitment, retention, and cultural appropriateness of clinical trial procedures in Africa.
• Site Training Services Site training services including GCP training and comprehensive clinical research training programs for site staff across Sub-Saharan Africa.
• Epidemiological Studies Epidemiological study services for observational research and population health studies across African populations.
• Patient Reported Outcome (PRO) / Quality of Life Research Patient-reported outcome (PRO) research services measuring quality of life and patient experience in clinical trials for sponsors.
• Post-Approval Safety Surveillance Post-approval safety surveillance services for monitoring product safety after market authorization for pharmaceutical and biotech sponsors.
• Investigational Product Management (IMP Logistics & IOR) Investigational Medicinal Product (IMP) logistics including regulatory approvals, import permits, cold-chain storage, dispensing, and Importer of Record (IOR) services in 40+ countries for clinical trial sponsors.
• Central Laboratory Services Central laboratory services for clinical trial specimen management and analysis across African sites for clinical trial sponsors.
• Outbreak Response Research Rapid and safe delivery of outbreak research for emerging and re-emerging infectious diseases using a pandemic response and preparedness playbook across Africa. Includes Ebola, COVID-19, and Mpox response capabilities.
• Capacity Building Services Global health research infrastructure development services including establishing new clinical research sites, equipment placement, and GCP training programs for sponsors and governments.
• Rescue Studies / Late-Phase Services Post-marketing and late-phase services including Phase IIIb and IV trials, observational studies, expanded access programs, post-authorization safety studies, and pharmacovigilance for approved products.
• Medical Monitoring Services Medical monitoring services providing medical and scientific expertise oversight for clinical trials conducted in Africa.
• Research Ready Sites Network Access to 60+ clinical research-ready sites and physician practices across Sub-Saharan Africa with standardized quality standards and centralized management for clinical trial sponsors.

Quantifiable outcome

• Ethics Committee Approval in 60 days with 95% Success Rate
• +6 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators13 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Worldwide Clinical Trials: Mid-sized global full-service CRO focused on complex Phase II–IV trials across multiple therapeutic areas. Comparable to ACE Research on full-service delivery and therapeutic specialization, though with global rather than Africa-only focus.
• Medpace: Mid-to-large full-service CRO with strong therapeutic area expertise and operational KPIs. Directly comparable to ACE Research on full-service Phase I–IV delivery model, though Medpace operates globally with a much larger headcount and tech stack.
• Novotech: Asia-Pacific-headquartered CRO that has expanded into Africa and other emerging markets. Comparable regional-specialist positioning to ACE Research, targeting sponsors seeking emerging-market patient diversity for clinical trials.
• PSI CRO: Full-service global CRO with strong presence in Central and Eastern Europe and emerging markets. Comparable mid-size CRO positioning to ACE Research, including patient recruitment expertise and full-service Phase I–IV offerings.
• Emmes Group: Mid-sized global CRO with government and academic research focus, including infectious disease and public health programs. Comparable to ACE Research on public-sector and outbreak-related research delivery, with overlapping biostatistics and data management capabilities.

Broad incumbents

• IQVIA: Global full-service CRO and life sciences services firm with growing Africa presence. Competes with ACE Research for multi-country African clinical trial programs, but operates as a broad incumbent across all geographies and therapeutic areas.
• ICON plc: Large global CRO offering full-service Phase I–IV capabilities including in Africa. Overlaps with ACE Research on clinical monitoring, data management, and biostatistics, but operates globally rather than as a regional Africa specialist.
• Parexel: Global full-service CRO with deep pharma/biotech client base and emerging Africa footprint. Comparable to ACE Research on Phase I–IV services and therapeutic area breadth, but with much larger scale and global preferred-provider status with top pharma.
• Syneos Health: Global biopharmaceutical solutions organization combining CRO and commercial services. Competes with ACE on full-service clinical trial execution and increasingly on emerging-market trial delivery, though with a global rather than Africa-centric footprint.

Regional players

• Lancet Laboratories: Major Africa-based clinical laboratory and diagnostics provider headquartered in South Africa with pan-African operations. Comparable to ACE Research on the Africa healthcare infrastructure footprint and central lab service overlap, though Lancet is primarily a diagnostic lab rather than a full-service CRO.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/aceresearchcro
• Facebookfacebook.com/AceresearchCRO
• LinkedInlinkedin.com/company/aceresearch

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ACE Research